# US 6,730,484 B2 · Methods for identifying ligand binding sites in a biomolecule

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,484 B2
- Document ID: US6730484B2
- Status: Granted
- Kind: B2
- Application number: 10/210,650
- Filed: 2002-07-31
- Published: 2003-09-04
- Granted: 2004-05-04
- Earliest claimed: 2001-02-22
- Assignees: Isis Pharmaceuticals, Inc.
- Inventors: Richard H. Griffey; Steven A. Hofstadler; Eric E. Swayze
- Web page: https://patentgrep.com/patent/US6730484B2

## CPC

- G01N 33/6842: {Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins}
- G01N 33/566: using specific carrier or receptor proteins as ligand binding reagents {where possible specific carrier or receptor proteins are classified with their target compounds}
- G01N 33/6848: {Methods of protein analysis involving mass spectrometry}
- C12Q 1/6811: Selection methods for production or design of target specific oligonucleotides or binding molecules
- G01N 2500/02: Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Methods of identifying ligand binding sites in a target molecule such as a polynucleotide or polypeptide, as well as methods for determining whether a particular site in a target molecule is at or near the ligand binding site, are provided. Ligand binding affinities corresponding to both the target molecule and a modified version thereof are compared, preferably using mass spectral analysis. The modified molecules, or test molecules, incorporate a modification capable of modulating ligand binding affinity when located at or near the ligand binding sites. Binding site information is derived from the known position of the modification.

## Claims

### Claim 1

A method of identifying a ligand binding site in a target molecule comprising:
(a) contacting said ligand with said target molecule under conditions that allow formation of a complex between said target molecule and said ligand;
(b) contacting said ligand with a test molecule under conditions that allow formation of a complex between said test molecule and said ligand, wherein said test molecule is said target molecule comprising a modification at a predetermined position wherein said modification is capable of modulating ligand binding affinity when said modification is located at or proximate to said ligand binding site in said target molecule;
(c) comparing the relative amount of target molecule-ligand complex to the relative amount of test molecule-ligand complex using a mass spectrometer;
(d) determining whether said predetermined position in said target molecule is at or proximate to said ligand binding site, wherein a difference in the relative amounts of target molecule-ligand complex and test molecule-ligand complex indicates that said ligand binds at or proximate to said predetermined position in said target molecule; and
(e) repeating steps (a)-(d) for different predetermined positions in said target molecule until one or more differences are detected, wherein said one or more differences identify said ligand binding site of said target molecule.

### Claim 2

A method for identifying a ligand binding site in a polynucleotide target molecule comprising:
(a) contacting a ligand with said polynucleotide target molecule under conditions that allow formation of a complex between said target molecule and said ligand;
(b) contacting said ligand with a test molecule under conditions that allow formation of a complex between said test molecule and said ligand, wherein said test molecule is said target molecule comprising a modification at a predetermined position wherein said modification is capable of modulating ligand binding affinity when said modification is located at or proximate to said ligand binding site in said target molecule;
(c) comparing the ligand binding affinity of said polynucleotide target molecule-ligand complex with the ligand binding affinity of test molecule-ligand complex;
(d) determining whether said predetermined position in said polynucleotide target molecule is at or proximate to said ligand binding site, wherein a difference in the ligand binding affinities of said polynucleotide target molecule-ligand complex and said test molecule-ligand complex indicates that said ligand binds at or proximate to said predetermined position in said polynucleotide target molecule; and
(e) repeating steps (a)-(d) for different predetermined positions in said polynucleotide target molecule until one or more differences in ligand binding affinity are detected, wherein said one or more differences identify said ligand binding site of said polynucleotide target molecule.

### Claim 3

A method of identifying a ligand binding site in a target molecule comprising:
(a) contacting a ligand with said target molecule under conditions that allow formation of a complex between said target molecule and said ligand;
(b) contacting said ligand with a set of test molecules under conditions that allow formation of complexes between said ligand and said test molecules, wherein each test molecule of said set is said target molecule comprising a modification at a predetermined position, wherein said predetermined position is different for each test molecule of said set, wherein said modification is capable of modulating ligand binding affinity when said modification is located at or proximate to said ligand binding site of said target molecule, wherein each test molecule of said set further comprises at least one mass tag substantially differentiating each of said test molecules of said set by mass;
(c) comparing the relative amount of target molecule-ligand complex to the relative amount of each test molecule-ligand complex using a mass spectrometer; and
(d) determining whether said predetermined position of each of said test molecules of said set is at or proximate to said ligand binding site, wherein a difference in the relative amount of target molecule-ligand complex and the relative amount of each test molecule-ligand complex indicates that said ligand binds at or proximate to said predetermined position, wherein one or more differences identify said ligand binding site.

### Claim 4 (depends on 3)

The method of claim 3 wherein said target molecule comprises at least one mass tag that substantially differentiates said target molecule from each of said test molecules of said set by mass.

### Claim 5 (depends on 4)

The method of claim 4 wherein said mass tags comprise polymer.

### Claim 6 (depends on 5)

The method of claim 5 wherein said polymer comprises polyethylene glycol, polypropylene, polystyrene, cellulose, sephadex, dextran, peptide, or polyacrylamide.

### Claim 7 (depends on 3)

The method of claim 3 wherein said target molecule comprises a polynucleotide, oligonucleotide, nucleic acid, peptide nucleic acid, RNA, DNA, or RNA/DNA hybrid.

### Claim 8 (depends on 3)

The method of claim 3 wherein said target molecule comprises a peptide, polypeptide, protein, receptor, or antibody.

### Claim 9 (depends on 3)

The method of claim 3 wherein said target molecule comprises an oligosaccharide, carbohydrate, or glycoprotein.

### Claim 10 (depends on 3)

The method of claim 3 wherein said test molecules comprise a modified nucleotide.

### Claim 11 (depends on 10)

The method of claim 10 wherein said modified nucleotide comprises a modified nucleobase.

### Claim 12 (depends on 11)

The method of claim 11 wherein said modified nucleobase comprises 5-substituted pyrimidines, 5-iodouracil, 5-iodocytosine, C5-propynyl pyrimidines, C5-propynylcytosine, C5-propynyluracil, N4-(C1-C12)alkylaminocytosines, N4,N4-(C1-C12)dialkylaminocytosines, 7-substituted-8-aza-7-deazapurines, 7-substituted-7-deazapurines, 7-iodo-7-deazapurines, 7-cyano-7-deazapurines, 7-aminocarbonyl-7-deazapurines, 6-amino-7-iodo-7-deazapurines, 6-amino-7-cyano-7-deazapurines, 6-amino-7-aminocarbonyl-7-deazapurines, 2-amino-6-hydroxy-7-iodo-7-deazapurines, 2-amino-6-hydroxy-7-cyano-7-deazapurines, 2-amino-6-hydroxy-7-aminocarbonyl-7-deazapurines, N6-(C1-C12)alkylaminopurines, N6,N6-(C1-C12)dialkylaminopurines, N6-methylaminoadenine, N6,N6-dimethylaminoadenine, 6-substituted purines, 6-thioguanine, 2-thiouracil, 8-bromoadenine, 8-bromoguanine, 2-fluoroadenine, or 2-fluoroguanine.

### Claim 13 (depends on 10)

The method of claim 10 wherein said modified nucleotide comprises a modified nucleosidic linking moiety.

### Claim 14 (depends on 13)

The method of claim 13 wherein said modified nucleosidic linking moiety comprises a phosphorothioate, diphosphorothioate, alkylphosphonate, or amidate.

### Claim 15 (depends on 10)

The method of claim 10 wherein said modified nucleotide comprises a modified ribose moiety.

### Claim 16 (depends on 15)

The method of claim 15 wherein said modified ribose moiety comprises 2′ modifications selected from the group consisting of 2′-deoxy, 2′-O-(C1-C40)alkyl, 2′-O-methyl, 2′-O-allyl, 2′-O-dimethylaminoethyl, 2′-O-methoxyethoxy, 2′-fluoro, 2′-amino, 2′-thio, and 2′-thiomethyl.

### Claim 17 (depends on 3)

The method of claim 3 wherein said test molecules each comprise a modified amino acid.

### Claim 18 (depends on 17)

The method of claim 17 wherein said modified amino acid is alanine.

### Claim 19 (depends on 3)

The method of claim 3 wherein said mass spectrometer is capable of producing detectable ions by electrospray ionization, atomospheric pressure ionization, or matrix-assisted laser desorption ionization.

### Claim 20 (depends on 3)

The method of claim 3 wherein said mass spectrometer includes mass analysis by quadrupole, quadrupole ion trap, time-of-flight, FT-ICR, or hybrid mass detectors.
